Emma Johnsen

• R&D Vice President for North America Adult & Feminine Care $2.5Bn business, covering front end innovation to execution for R&D, Engineering & Packaging (95+ professionals) for no.1 mega brands Depend & Poise & leading Kotex and Thinx brands.
• Positioned in role to onslaught innovation. Shaped & successfully led the highest single incremental growth initiative for Kimberly-Clark, over $100M+, by out-innovating competition through fresh new strategic thinking on consumer, product portfolio and innovation agility.
• Personally recognised by Kimberly-Clark's CEO for success of strategic redesign R&D across $7Bn business - North America Adult & FemCare, International Family Care & Professional B2B, and Enterprise Personal Care. A cornerstone of the company's largest transformation in 150 years realising $200M savings over two years and focused on innovation growth.
• Successfully leading the growth ambition innovation portfolio for half of Kimberly-Clark's brands with $200M+ net sales growth for underpinning a $2Bn U.S. manufacturing expansion to accelerate market leadership and deliver bold domestic growth.
• Deep expertise in FDA classifications and regulatory compliance, with hands-on leadership across tampons, wipes, adult & period care, and microbiome-related product formats to ensure end-to-end regulatory excellence in highly regulated categories.

• Vice President Global Innovation for Kimberly-Clark's $3.6B Professional B2B business including Global Category Marketing and R&D (140 professionals) and directly reported to KC board member.
• Doubled incremental innovation contribution to 40% of net sales through Strategic Business Planning, while redesigning globally and locally relevant, customer-driven brand and product strategies - laying the foundation for sustained portfolio growth ahead of a major business restructuring.
• Led the Innovation separation for the strategic split of Kimberly-Clark's $640MM PPE operations acquired by Ansell,
• Elevated KCP Sustainability maturity, through deep integration with customer partnerships and advancement of circularity-driven services across washroom and wipers categories.

• Built the Kotex Feminine Care business across EMEA from the ground up with a start-up mindset inside a global enterprise — scaling with double digit growth and 30–50% organic YoY growth in 2020-'2022 achieving 25%+ market share in Y6. Developed a consumer-winning, needs-based portfolio and optimised gross margin to >35% through strategic supply design blending in-house investment and APAC sourcing.
• Simultaneously held roles as Regional Business Leader and R&D Director for Adult and Feminine Care during the first year of the Russia/Ukraine conflict. Re-shaped the portfolio, business operations, and organisational structure to navigate global sanctions, while upholding Kimberly-Clark's Values and ensuring business continuity and achieved 30% organic growth in year.
• Withheld the strongest company culture & leadership scores in 2022 in EMEA region.
• Promoted to R&D Personal Care Director with expanded responsibility across Baby & Child Care (BCC) in addition to Adult and Feminine Care. Transformed EMEA BCC $500M net sales business from consumer decline due to competitive reset, to significant winning propositions across all category tiers in key markets, delivering margin-accretive results with minimal supply disruption.

• Product leader for Baby & Child Care category expansion across MEA, spearheading the first-ever local diaper manufacturing in Russia, South Africa, and Israel with consumer centric portfolio — driving significant cost efficiencies and unlocking sustained market share growth
• Product lead in turning around a declining UK baby wipes portfolio by anchoring innovation in top consumer insight — transforming a losing product system into both a P&L and consumer win through strategic cost restructuring and enhanced user experience.
• R&E Manager leading product workstream for closure and asset redeployment of Turkey mill operations. Successfully transferred production to alternative sites for business continuity, safeguard brand equity, and enhanced cost and supply resilience during sensitive transition.
• Extensive end to end product development expertise from FEI to in-market execution, built through hands on development roles across B2B and Consumer across KC brands.

Led and coordinated fundamental research initiatives with suppliers linked to Essity, driving improvements in total system diaper performance. Successfully secured and managed industry- and government-funded projects, resulting in peer-reviewed publications and measurable advancements in applied research.

Developed and executed high-performance liquid chromatography (HPLC) methods to analyse chemical properties and determine purity of novel active pharmaceutical ingredients in pre-clinical and clinical development phases